Related Experiment Video

Updated: Jun 5, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

Allogeneic hematopoietic stem cell transplantation for childhood aplastic anemia: prospective trial in China

Chen Chun1, Jian-pei Fang, Hong-man Xue

  • 1Department of Pediatrics, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China. chenchun69@126.com

Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis
|January 25, 2011
PubMed

Insights

Allogeneic hematopoietic stem cell transplants offer a promising treatment for children with severe aplastic anemia (SAA). This study shows high survival rates and successful engraftment, making it a viable option.

Area of Science:

  • Hematology
  • Pediatric Oncology
  • Transplantation Medicine

Background:

  • Severe aplastic anemia (SAA) is a life-threatening condition in children.
  • Hematopoietic stem cell transplantation (HSCT) is a potential curative therapy.
  • Limited prospective data exists for HSCT in pediatric SAA in China.

Purpose of the Study:

  • To evaluate the efficacy and safety of allogeneic HSCT in children with SAA.
  • To report outcomes from the first prospective trial in China for this indication.

Main Methods:

  • Six children with SAA underwent HSCT with chemotherapy.
  • Utilized fully matched allogeneic donors.
  • Prospective trial design with a mean follow-up of 2.75 years.

Main Results:

  • Successful engraftment was achieved in five patients (83%).
  • One patient achieved spontaneous autologous hematopoiesis.
  • Overall survival rate was 83% (5/6 patients).

Conclusions:

  • Allogeneic HSCT is an effective and safe treatment for pediatric SAA.
  • This approach offers a favorable option for children requiring SAA treatment.
  • The findings support HSCT as a standard of care for SAA in pediatric populations.

More Related Videos

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice03:40

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Published on: December 8, 2023

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...